title: Transjugular intrahepatic portosystemic shunt prior to renal transplantation in a child with autosomal-recessive polycystic kidney disease and portal hypertension: A case report.
abstract: Autosomal-recessive polycystic kidney disease (ARPKD) can cause renal failure and portal hypertension in children. Portal hypertension may complicate the course of renal transplantation (Tx). We report the successful outcome of a patient with end-stage renal disease (ESRD) and portal hypertension treated with transjugular intrahepatic portosystemic shunt (TIPS), a minimally invasive endovascular technique of portosystemic shunt, prior to renal Tx.
authors: Divisions of Pediatric Nephrology and Gastroenterology, Department of Pediatrics, UCSD School of Medicine, La Jolla, CA 92093-0831, USA. nbenador@ucsd.edu
authors: N
authors: N
authors: Benador
authors: P
authors: P
authors: Grimm
authors: J
authors: J
authors: Lavine
authors: P
authors: P
authors: Rosenthal
authors: V
authors: V
authors: Reznik
authors: J
authors: J
authors: Lemire
mesh_terms: D002648:Child; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control; D006801:Humans; D006975:Hypertension, Portal / Q000150:complications* / Q000235:genetics / Q000601:surgery*; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007676:Kidney Failure, Chronic / Q000209:etiology / Q000235:genetics / Q000601:surgery; D016030:Kidney Transplantation; D017044:Polycystic Kidney, Autosomal Recessive / Q000150:complications* / Q000235:genetics / Q000601:surgery*; D019168:Portasystemic Shunt, Transjugular Intrahepatic
chemical_list: D007166:Immunosuppressive Agents